Anlotinib, Toripalimab and Nab-paclitaxel in Locally Advanced/Metastatic Pancreatic Cancer
Clinical trial NCT04718701 · UNKNOWN
Trial details
- NCT number
- NCT04718701
- Sponsor
- The First Affiliated Hospital with Nanjing Medical University
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-04-01
- Primary completion
- 2023-02-01
- Enrollment
- 53
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.